Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective
Publication date: Available online 6 November 2026 Source: Journal of Pediatric Health Care Author(s): Karah Brashier, Katherine H. Peppers, Stephanie Shafer
Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective. // Journal of Pediatric Health Care. – URL: https://www.sciencedirect.com/science/article/pii/S0891524526003317?dgcid=rss_sd_all
Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective. Journal of Pediatric Health Care. https://www.sciencedirect.com/science/article/pii/S0891524526003317?dgcid=rss_sd_all
“Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective.” Journal of Pediatric Health Care.
@article{article54561,
title = {Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective},
journal = {Journal of Pediatric Health Care},
url = {https://www.sciencedirect.com/science/article/pii/S0891524526003317?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...